Source: PLOS ONE. Unidades: FZEA, FMVZ
Subjects: ANTINEOPLÁSICOS, NEOPLASIAS PULMONARES
ABNT
FUKUMASU, Heidge et al. Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells. PLOS ONE, v. 9, n. 6, p. e99484-1-e99484-10, 2014Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0099484. Acesso em: 03 maio 2024.APA
Fukumasu, H., Rochetti, A. de L., Pires, P. R. L., Silva, E. R. da, Mesquita, L. G., Strefezzi, R. de F., et al. (2014). Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells. PLOS ONE, 9( 6), e99484-1-e99484-10. doi:10.1371/journal.pone.0099484NLM
Fukumasu H, Rochetti A de L, Pires PRL, Silva ER da, Mesquita LG, Strefezzi R de F, Carvalho DD de, Dagli MLZ. Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells [Internet]. PLOS ONE. 2014 ; 9( 6): e99484-1-e99484-10.[citado 2024 maio 03 ] Available from: https://doi.org/10.1371/journal.pone.0099484Vancouver
Fukumasu H, Rochetti A de L, Pires PRL, Silva ER da, Mesquita LG, Strefezzi R de F, Carvalho DD de, Dagli MLZ. Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells [Internet]. PLOS ONE. 2014 ; 9( 6): e99484-1-e99484-10.[citado 2024 maio 03 ] Available from: https://doi.org/10.1371/journal.pone.0099484